Minerva Neurosciences (NERV)
(Delayed Data from NSDQ)
$2.53 USD
+0.09 (3.79%)
Updated Apr 23, 2024 03:59 PM ET
After-Market: $2.49 -0.04 (-1.58%) 6:14 PM ET
4-Sell of 5 4
D Value B Growth C Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (93 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.00 | 1.52 | 9.99 |
Current Quarter Estimate | -1.20 | -2.04 | 60.00 |
Year Ago Quarter Estimate | -1.31 | -0.59 | 52.54 |
Next Quarter Estimate | -0.77 | -2.00 | 61.00 |
Next Year Estimate | -4.54 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 22.56 | 10.20 | 17.08 |
Next Year | -27.17 | 13.80 | 8.00 |
Last 5 Years | NA | 5.90 | 8.10 |
Next 5 Years | NA | 22.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | NA | 1.73 |
Price/Cash Flow (MRFY) | NA | 8.52 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -19.76% |
Return on Equity (TTM) | NA | -75.03% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.